GlassScriptPhysician profile
Morgan Burke
NPI 1063815082
$5,077.97
in general payments reported to CMS, 2019-2025
13 companies · $2,877 in 2025
The $2,877 reported for 2025 was more than what 97% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.57 · 2022: $18.69 · 2023: $1,612 · 2024: $550 · 2025: $2,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537 · Consulting Fee: $1,650 · Travel and Lodging: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,536.81 |
| Consulting Fee | $1,650.00 |
| Travel and Lodging | $852.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,654.74 | 2023-2025 | Titan |
| Axonics, INC. | $933.54 | 2023-2024 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $130.02 | 2023-2024 | Xiaflex |
| Sumitomo Pharma America, INC. | $114.42 | 2023-2024 | Gemtesa |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Urogen Pharma, INC. | $45.85 | 2024 | |
| Boston Scientific Corporation | $41.25 | 2023-2025 | Axonics, Rezum Generator |
| Cycle Pharmaceuticals INC | $21.59 | 2025 | Venxxiva |
| Astellas Pharma US INC | $21.44 | 2024 | Myrbetriq |
| Photocure INC | $19.57 | 2021 | |
| Urovant Sciences INC | $18.69 | 2022 | |
| Abc Home Medical Supply, INC. | $13.43 | 2024 | |
| Hollister Incorporated | $13.43 | 2024 | Vapro Pocket |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.